AVGO’s 5.2% Drop Doesn’t Break the Growth Case

I can’t attribute today’s −5.17% move to a cause from the data provided, and it does not change my view: the pullback looks sharper than the available fundamentals justify, though it is not proof of an overreaction. Q3 2026 revenue rose 85.5% year over year, net income 216.1%, and free cash flow 94.5%, showing powerful growth with cash generation. Consensus expects FY 2027 EPS of $19.465, up 66.9%, and the estimated P/E falls to 17.8x from 29.6x for FY 2026. The shares are already 28.2% below their 52-week high, while the median analyst target of $535 implies 54.8% upside. AVGO is already 21.2% of my portfolio, so I’ll add modestly rather than let concentration run away: buy with 5% of cash.